Key result
Warfarin therapy was associated with the development of warfarin-induced skin necrosis in a 20-year-old female patient treated for postoperative femoropopliteal deep vein thrombosis.
Case Report (n=1)
Highlights a rare but serious case of warfarin-induced skin necrosis in a young patient treated for postoperative deep vein thrombosis.
Answers are grounded in this paper and cite their sources.
Alerts clinicians to rare warfarin skin necrosis in young postoperative DVT; leaves open systematic risk-factor evaluation.
Oral anticoagulants are associated with several adverse skin manifestations ranging from ecchymosis, purpura, and hemorrhagic necrosis to maculopapular rash, vesicular urticarial eruptions and purple toes. Skin necrosis is a rare but serious side effect of warfarin therapy, associated with significant morbidity and mortality. The prevalence of warfarin induced skin necrosis (WISN) is 0.01-0.1%. We report a 20-year-old female patient of craniopharyngioma who developed WISN following postoperative femoropopliteal deep vein thrombosis.
No takes yet. Share an insight, caveat, or question.
Bhat et al. (2006) conducted a case report in Craniopharyngioma and postoperative femoropopliteal deep vein thrombosis (n=1). Warfarin was evaluated on Warfarin induced skin necrosis. Warfarin therapy was associated with the development of warfarin-induced skin necrosis in a 20-year-old female patient treated for postoperative femoropopliteal deep vein thrombosis.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: